Walleye Trading LLC Vir Biotechnology, Inc. Call Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $122,960 - $144,637	5,300 New	5,300 $130,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $283,946 - $536,134	-13,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $836,190 - $1.46 Million	-27,000 Reduced 66.83%	13,400 $561,000
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $1.41 Million - $2.2 Million	40,400 New	40,400 $1.76 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $258,132 - $814,085	-9,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $249,998 - $425,124	9,800 New	9,800 $262,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.